Cocrystal Pharma Inc expected to post a loss of 58 cents a share - Earnings Preview

Cocrystal Pharma

11/08/2023 17:10

* Cocrystal Pharma Inc  COCP.OQ   COCP.O  is expected
to show a
rise in quarterly revenue when it reports  results on August 14
(estimated). 
    * The Bothell Washington-based  company is expected to
report
revenue of $266.67 thousand, according to the mean estimate from
3 analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Cocrystal Pharma
Inc is
for a loss of 58 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cocrystal
Pharma
Inc is $10​, above​ its last closing price of $2.95. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.59       -0.67      -0.64     Beat    5.2
 Dec. 31 2023  -0.72       -0.73      -0.55     Beat    24.3
 Sep. 30 2022  -0.48       -0.48      -0.70     Missed  -45.8​
 Jun. 30 2022  -0.54       -0.52      -3.00     Missed  -477
 ​​Mar.        -0.36       -0.42      -0.48     Missed  -14.3
 31 2022                                                
 Dec. 31 2021  -0.48       -0.48      -0.48     Met     0​
 Sep. 30 2021  -0.48       -0.48      -0.48     Met     0
 Jun. 30 2021  -0.42       -0.42      -0.48     Missed  -14.3
 This summary was machine generated August 11 at 16:10 GMT.  All
figures in US dollars  unless otherwise stated